渣打(02888.HK)擬斥2,333萬美元入股新加坡區塊鏈跨境支付平台
渣打(02888.HK)全資附屬公司SCOHL與Partior訂立股份認購協議。據此,SCOHL同意按價格每股認購股份2.573美元,認購於Partior的認購股份,總認購價為2,333.28萬美元,以收購Partior的25%股權,惟必須滿足若干條件。
Partior總部設於新加坡。其營運以區塊鏈為基礎的跨境支付和價值交換平台,可進行多種貨幣的數字清算和結算。
由於Temasek為渣打的主要股東,因此Temasek為渣打的關連人士。由於Temasek持有其超過30%的已發行股本,故此Partior為渣打的關連人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.